Genetic polymorphisms in glutathione S-transferase M1 and T1 in an Australian aborigine population

Pharmacogenetics

Volumn 10, Issue 5, 2000, Pages 477-480

  Hett, Kenneth F ^a,b   McCormick, Neil ^a   Carpenter, Denise S ^a   Spargo, Randolph M ^e   Le Souef, Peter N ^a   Musk, A William ^c   Minchin, Rodney F ^a,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b W Aust Ctr for Pathol Med Res   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e NONE

Author keywords

Australian aborigine; Genetic polymorphism; GSTM1; GSTT1

Indexed keywords

GLUTATHIONE TRANSFERASE;

ABORIGINE; ARTICLE; AUSTRALIA; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL;

ADULT; CHILD; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; OCEANIC ANCESTRY GROUP; POLYMORPHISM, GENETIC; WESTERN AUSTRALIA;

EID: 0033918742     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200007000-00011     Document Type: Article

References (36)

1. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 1998; 22:129-138.
2. Alberti G, Oguni M, Podgor M, Sperduto RD, Tomarev S, Grassi C. et al. Glutathione S-transferase M1 genotype and age-related cataracts. Lack of association in an Italian population. Invest Opthalmol Vis Sci 1996; 37:1167-1173.
3. Anttila S, Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Nurminen T, Vainio H. Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 1994; 15:1133-1135.
4. Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM, Au WW. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 1996; 17:1923-1929.
5. Arruda VR, Grignolli CE, Goncalves MS, Soares MC, Menezes R, Saad ST, et al. Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis? Clin Genet 1998; 54:210-214.
6. Autrup H, Daneshvar B, Dragsted LO, Gamborg M, Hansen M, Loft S, et al. Biomarkers for exposure to ambient air pollution - comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress. Environ Health Perspect 1999; 107:233-238.
7. Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 1997; 99:822-826.
8. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL. Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. JNCI 1993; 85:1159-1164.
9. Breguet G, Butler R, Butler-Brunner E, Sanchez-Mazas A. A worldwide population study of the Ag-system haplotypes, a genetic polymorphism of human low-density lipoprotein. Am J Hum Genet 1990; 46:502-517.
10. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res 1993; 53:1004-1011.
11. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994; 54:4103-4111.
12. Bruhn C, Brockmoller J, Kerb R, Roots I, Borchert HH. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochem Pharmacol 1998; 56:1189-1193.
13. Chen C, Madeleine MM, Lubinski C, Weiss NS, Tickman EW, Daling JR. Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study. Cancer Epidemiol Bio Prev 1996; 5:985-991.
14. Daly AK, Cholerton S, Armstrong M, Idle JR. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 1994; 102 (Suppl 166):61.
15. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jap J Cancer Res 1992; 83:866-870.
16. Ilett KF, Chiswell GM, Spargo RM, Platt E, Minchin RF. Acetylation phenotype and genotype in Aboriginal leprosy patients from the north-west region of Western Australia. Pharmacogenetics 1993; 3:264-269.
17. Jahnke V, Matthias C, Fryer A, Strange R. Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg 1996; 172:671-673.
18. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996; 17:1855-1859.
19. Kihara M, Kubota A, Furukawa M, Kimura H. GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett 1997; 112:257-262.
20. Lee EJ, Wong JY, Yeoh PN, Gong NH. Glutathione S-transferase theta (GSTT1 ) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics 1995; 5:332-334.
21. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Bio Prev 1995; 4:589-594.
22. Mukanganyama S, Masimirembwa CM, Naik YS, Hasler JA. Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A. Clin Chim Acta 1997; 265:145-155.
23. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993; 53:2994-2999.
24. Oke B, Akbas F, Aydin M, Berkkan H. GSTT1 null genotype frequency in a Turkish population [letter]. Arch Toxicol 1998; 72:454-455.
25. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Bio Prev 1997; 6:733-743.
26. Refetoff S, Murata Y. X-chromosome-linked inheritance of the variant thyroxine-binding globulin in Australian Aborigines. J Clin Endocrinol Metab 1985; 60:356-360.
27. Roy B, Dey B, Chakraborty M, Majumder PP. Frequency of homozygous null mutation at the glutathione-s-transferase M1 locus in some populations of Orissa, India. Anthropol Anzeiger 1998; 56:43-47.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989, pp. 16-19.
29. Sergeantson S. The colonization of the Pacific. A genetic trail. Oxford, UK: Clarendon Press, 1989, pp. 286-294.
30. Shen J, Lin G, Yuan W, Tan J, Bolt HM, Thier R. Glutathione transferase T1 and M1 genotype polymorphism in the normal population of Shanghai [letter]. Arch Toxicol 1998; 72:456-458.
31. Strange RC, Lear JT, Fryer AA. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem-Biol Interact 1998a; 111-112:351-364.
32. Strange RC, Lear JT, Fryer AA. Polymorphism in glutathione S-transferase loci as a risk factor for common cancers. Arch Toxicol 1998b; 20:419-428.
33. Threlfall TJ, Thompson JR. Cancer incidence and mortality in Western Australia, 1997. Statistical series number 57. Perth: Health Department of Western Australia, 1999, pp. 35-36.
34. Trejaut J, Bhatia K, Greville WD, Hu KR, Duraisamy G, Nuchprayoon C, et al. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian Aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022. Eur J Immunogenet 1996; 23:437-449.
35. Trejaut J, Greville W, Duncan N, Dunckley H. A novel DRB1 allele (DRB1*0815) defined in an Australian Aborigine. Tissue Antig 1997; 49:529-531.
36. Wormhoudt LW, Commandeur JN, Vermeulen NP. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione S-transferase, and epoxide hydroxylase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 1999; 29:59-124.